Babak formerly served as VP Product, Arterys leading AI Development and  Product Strategy. His team consists of PhDs, MDs & relevant industry experts who work closely with internal dev teams and our customers to ensure the highest clinical value. Babak received his PhD In Computer Vision And Robotics from KTH Royal Institute Of Technology.

‍

Clarence joined Salesforce in their founding year and has spent more than 20 years growing the company in a variety of leadership roles including Chief Marketing Officer, EVP Product Management and Chief Strategy Officer. Clarence has also led many of Salesforce’s initiatives into healthcare delivery and serves as an advisor and mentor to several healthcare startups. Prior to Salesforce, Clarence worked in engineering, product management, and venture capital roles at Motorola Semiconductor, Arbor Software and US Venture Partners. Clarence holds an MBA from University of California, Berkeley and an Electrical Engineering degree from Queen’s University, Kingston Ontario.

As an investor at CRV, Kristin partners with tech founders who are transforming the health industry. She has built teams from the earliest stages through IPO, including leading go-to-market at Collective Health as the Chief Commercial Officer, where customers included Palantir, SpaceX and Uber; and building health plan and PBM partnerships and running finance and investor relations at Castlight Health. Kristin received her BA from Middlebury College and MBA from Stanford University.

Michael is an experienced C-suite executive with deep expertise in corporate development, mergers & acquisitions (M&A), strategy, equity & debt capital markets, equity investing/venture capital, market development, partnerships. He previously worked at the General Electric Company (“GE”) for over 21 years, having joined the company in 1998.  From 1998 through 2010, he was the Executive Vice President, Corporate Development/M&A, for GE Healthcare (“GEHC”) based in London, United Kingdom, and Milwaukee, Wisconsin. In that role, he was a member of the senior leadership team at GEHC and was responsible for developing the overall strategy for the business and leading its corporate development, M&A, equity investing and partnership activities. During his time at GEHC, the business grew from approximately $2 billion to $18 billion in annual revenues and completed over 100 transactions worldwide valued in excess of $20 billion. He was also responsible for launching GE’s healthcare venture fund in 2010, which made growth capital and venture investments in numerous med-tech companies. From 2014 until his retirement from GE he served as its Executive Vice President, Corporate Development/M&A, responsible for leading GE’s corporate development and M&A across all of its industrial businesses. Over the 2014-2019 time period, GE completed over $50 billion in mergers and acquisitions and $30 billion in divestitures. Prior to joining GE, Michael spent over a decade working as an investment banker in New York and San Francisco, primarily as an M&A advisor for technology companies. He graduated from Princeton University with an A.B. in Economics, with honors, in 1987. Michael resides in Greenwich CT with his wife Kelly and their three children.

Mike brings 35+ years of business development, consulting, and executive experience in the healthcare technology. At Mercy Virtual, he led the commercialization efforts for the country’s first Virtual Care Center that developed over 14 virtual lines of business within its $7 billion dollar health system. He has served in executive positions at both vendors and health system and developed extensive relationships across vendor, provider, and consulting communities. He has extensive experience go to market strategy, joint ventures and partnerships, technology analysis and evaluation, clinical workflow solution development and technology and service contract negotiation. Mike holds BBA and MBA degrees in Finance and Management. He currently enjoys an executive position at a Memphis-based healthcare technology advisory firm.

Oran endeavors to use more than thirty years of healthcare industry experience to solve the puzzle of reimbursement, better outcomes and more scalable solutions in healthcare. He has started 5 companies (3 acquired). In 1998, he co-founded and became CEO of Stentor and redefined PACS based on a service and delivery model. After its acquisition by Philips in 2005, Oran became the CEO of HealthInformatics at Philips Medical Systems, where he was responsible for the horizontal clinical applications. In the early 1990s, he served as vice president of sales and marketing at Cemax, an early pioneer in image management and advanced visualization, and prior to that, he was a senior product manager at Toshiba Medical, where he introduced the company’s new CT scanners in the United States. Oran received his Bachelor of Science in Engineering from Kings College in London. He is a member of the Board of Directors for Amirsys, Vital Images and Median Technologies.

Ryan is a Social Entrepreneur and Founder Advocate with a focus on delivering better health and saving lives through the delivery and use of technology. He has been recognized as a Technology Pioneer by the World Economic Forum, one of the Top 40 under 40 by the San Francisco Business Times, one of the 100 Most Intriguing Entrepreneurs of 2013 by Goldman Sachs, and as one of the Silicon Valley Top 100 by Business Insider. In 2005 Ryan founded Practice Fusion and grew it into the largest Electronic Health Record Platform for doctors and patients in the US. Practice Fusion exited to Allscripts in 2018. In 2016 he founded 100Plus, the fastest-growing Remote Patient Monitoring Platform in the US assisting seniors in monitoring their chronic conditions. 100Plus exited to Connect America in 2021. Ryan now partners with founders on how to design their companies and implement controls within in their articles of incorporation, board structure, and founder employment agreements. Ensuring that they can maintain control of their companies and achieve a positive financial outcome.

Sendhil Mullainathan is the Roman Family University Professor of Computation and Behavioral Science at Chicago Booth. His current research uses machine learning to understand complex problems in human behavior, social policy, and especially medicine, where computational techniques have the potential to uncover biomedical insights from large-scale health data. In addition to being a co-PI at the joint Berkeley-UChicago Laboratory for Systems Medicine, Sendhil is the cofounder of the computational medicine initiative, Nightingale. He’s also a co-founder of Pique, a an app that changes how people read books and learn; and Dandelion, a company that catalyzes AI in healthcare. In past work he has combined insights from economics and behavioral science with causal inference tools—lab, field, and natural experiments—to study social problems such as discrimination and poverty. Papers include: the impact of poverty on mental bandwidth; how algorithms can improve on judicial decision-making; whether CEO pay is excessive; using fictitious resumes to measure discrimination; showing that higher cigarette taxes makes smokers happier; and modeling how competition affects media bias. Sendhil enjoys writing. He recently co-authored Scarcity: Why Having too Little Means so Much and writes regularly for the New York Times. Additionally, his research has appeared in a variety of publications including the Quarterly Journal of Economics, American Economic Review, Social Cognition, British Medical Journal, and Management Science. Sendhil helped co-found a non-profit to apply behavioral science (ideas42), co-founded a center to promote the use of randomized control trials in development (the Abdul Latif Jameel Poverty Action Lab), serves on the board of the MacArthur Foundation, has worked in government in various roles, is affiliated with the NBER and BREAD, and is a member of the American Academy of Arts and Sciences. Prior to joining Booth, Sendhil was the Robert C. Waggoner Professor of Economics in the Faculty of Arts and Sciences at Harvard University, where he taught courses about machine learning and big data. He began his academic career at the Massachusetts Institute of Technology. Sendhil is a recipient of the MacArthur “Genius Grant,” has been designated a “Young Global Leader” by the World Economic Forum, was labeled a “Top 100 Thinker” by Foreign Policy Magazine, and was named to the “Smart List: 50 people who will change the world” by Wired Magazine (UK). His hobbies include basketball, board games, googling, and fixing up classic espresso machines.